Supernus Pharmaceuticals
SUPN
#4266
Rank
S$3.57 B
Marketcap
S$61.58
Share price
-2.37%
Change (1 day)
47.02%
Change (1 year)

Market capitalization of Supernus Pharmaceuticals (SUPN)

Market cap: S$3.57 Billion

As of May 2026 Supernus Pharmaceuticals has a market cap of S$3.57 Billion. This makes Supernus Pharmaceuticals the world's 4266th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Supernus Pharmaceuticals from 2012 to 2026

End of year Market Cap

Year Marketcap Change
2026S$3.57 B-5.86%
2025S$3.79 B36.04%
2024S$2.79 B33.64%
2023S$2.08 B-19.22%
2022S$2.58 B23.3%
2021S$2.09 B19.14%
2020S$1.75 B4.75%
2019S$1.67 B-29.24%
2018S$2.37 B-13.1%
2017S$2.73 B50.92%
2016S$1.81 B94.32%
2015S$0.93 B97.67%
2014S$0.47 B23.39%
2013S$0.38 B42.26%
2012S$0.26 B

End of Day market cap according to different sources

On May 24th, 2026 the market cap of Supernus Pharmaceuticals was reported to be:

S$3.57 Billion
by Nasdaq info icon info icon
S$3.57 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
S$720.50 B 20,060.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
S$194.46 B 5,341.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$1.213 T 33,841.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$155.08 B 4,239.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Zogenix
ZGNX
S$1.91 B-46.39%๐Ÿ‡บ๐Ÿ‡ธ USA
United Therapeutics
UTHR
S$30.81 B 762.30%๐Ÿ‡บ๐Ÿ‡ธ USA